Diane G. Gerst - Jun 30, 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Jun 30, 2022
Transactions value $
-$76,945
Form type
4
Date filed
7/5/2022, 04:06 PM
Previous filing
Jun 14, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $66.8K +3.33K +25.95% $20.03 16.2K Jun 30, 2022 Direct
transaction AMPH Common Stock Options Exercise $36.4K +1.81K +11.21% $20.08 18K Jun 30, 2022 Direct
transaction AMPH Common Stock Sale -$180K -5.15K -28.61% $35.00 12.8K Jun 30, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -3.33K -47.89% $0.00 3.63K Jun 30, 2022 Common Stock 3.33K $20.03 Direct F2
transaction AMPH Stock Option (right to buy) Options Exercise $0 -1.81K -22.65% $0.00 6.19K Jun 30, 2022 Common Stock 1.81K $20.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
F2 Shares subject to the option are fully vested and immediately exercisable.